{"source":"Breaknorm","page":"https://breaknorm.co/company/arvinas.com","license":"https://breaknorm.co/terms","domain":"arvinas.com","name":"Arvinas","legal_name":"Arvinas","country":"US","country_second":"CZ","city":"New Haven","admin1":"Connecticut","vertical":"community_associations_public","subvertical":"research_institutes_and_think_tanks","leaf":"biotech_medtech_rnd","summary":"Arvinas is a biotechnology company that develops targeted protein degradation therapeutics, including the first FDA-approved PROTAC, for patients with serious diseases. Its offerings include investigational research and a pipeline of PROTAC protein degrader treatments in oncology and neurology. The company also runs clinical trials and expanded access programs.","offerings":["FDA-approved PROTAC therapy","investigational research"],"target_customers":["patients with serious diseases","oncology and neurology"],"business_model":["B2C"],"geo_scope":"unknown","headcount":"201-500","headcount_source":"linkedin","revenue":"50M-250M","revenue_source":"estimated","certifications":[],"langs":["en"],"linkedin":"https://www.linkedin.com/company/arvinas","reviews":[],"contact_points":5,"contact_phones":1,"page_types":["pricing","home","contact","careers","leadership"],"crawled":"2026-09-06","profiled":"2026-09-12","indexed":"2026-09-19","hiring_built":"2026-10-27","website_tech":["apple","atlassian","atlassian_statuspage","campaign_monitor","canva","docusign","knowbe4","microsoft_365","microsoft_entra_id","microsoft_intune","microsoft_teams","mimecast_dmarc_analyzer","nintex","openai","oracle_netsuite","smartsheet"],"hiring":{"open":1,"open_postings":1,"new_7d":0,"new_30d":1,"new_90d":1,"closed_30d":0,"countries":[]},"hiring_functions":[["research_and_science",1,1]],"tech_jobs":[],"intents":[],"recent_postings":[{"id":146708,"title":"Medicinal Chemistry Project Leader","city":"Remote","function":"research_and_science","family":"research_and_science/scientific_research","seniority":"senior","posted":"2026-10-02","url":"https://job-boards.greenhouse.io/arvinas/jobs/8011985003","tech":[]}],"ats":"Greenhouse","similar":[{"domain":"alnylam.ca","name":"Alnylam","country":"CA","city":"Mississauga (West Rathwood / East Hurontario / SE Gateway)","headcount":"51-200","leaf":"biotech_medtech_rnd","summary":"Alnylam is a biopharmaceutical company that develops RNA interference (RNAi)-based medicines to silence disease-causing genes."},{"domain":"alnylam.de","name":"Alnylam","country":"DE","city":null,"headcount":"501-1000","leaf":"pharmaceutical_manufacturers","summary":"Alnylam is a pharmaceutical company that develops RNAi therapeutics to silence disease-causing genes."},{"domain":"visterrainc.com","name":"Visterra","country":"US","city":null,"headcount":"51-200","leaf":"biotech_medtech_rnd","summary":"Visterra is a biologics research company that develops therapies for patients with immune-mediated and other hard-to-treat diseases."},{"domain":"alnylam.it","name":"Alnylam","country":"IT","city":"Milano","headcount":"1001-5000","leaf":"pharmaceutical_manufacturers","summary":"Alnylam is a pharmaceutical company that is a leader in RNAi therapies, developing drugs that silence genes causing or contributing to disease."},{"domain":"apellis.com","name":"Apellis","country":"US","city":"Cambridge","headcount":"501-1000","leaf":"pharmaceutical_manufacturers","summary":"Apellis is a biotechnology company that develops medicines for patients with rare diseases, focusing on complement science."},{"domain":"amgen.dk","name":"Amgen","country":"DK","city":"København Ø","headcount":"51-200","leaf":"biotech_medtech_rnd","summary":"Amgen is a biotechnology company that uses science and technology to develop treatments for patients with serious diseases."}],"similar_scored":581,"customers":null,"as_of":"2026-11-02","updated_at":"2026-11-02","hash":"b5f56fe29566a6e9","index_tier":1}